Vertex, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $VERX in the last 7 days.
No SEC Form 4 filings for $VERX in the last 30 days.
See all $VERX insider activity →Vertex, Inc. (VERX) shares rose about 6.5% after it reported Q2 revenue of $203.97 million and returned to quarterly profitability. The company updated 2026 guidance and named three senior leaders, including Bala Chandran as Chief Product and Technology Officer, to support SaaS and AI initiatives and international expansion.
Simply Wall St reports Vertex (VERX) posted Q2 2026 revenue of $203.97 million and positive net income, updated revenue guidance, and appointed three senior leaders. The article cites a fair value of $18.54 versus a $13.26 latest close, implying 29% undervaluation, and links upside to European e-invoicing mandates in 2026-2027.
Vertex, Inc. (VERX) reported Q2 2026 revenue of $204 million, up 10.5% year over year and at the high end of guidance. Adjusted EBITDA rose 33% to $51 million, with margin expanding to 25.0%. Subscription revenue grew to $174.8 million and ARR reached $703.4 million. Full-year revenue guidance was narrowed to $825-$830 million and adjusted EBITDA guidance raised to $206-$210 million.
Recent VERX coverage spans earnings, market movers and financial news.
The article frames a near-term earnings and guidance reset plus AI/product leadership hires, which can support a positive re-rating if execution follows.
The article frames VERX as potentially undervalued after Q2 results and guidance, but it provides no specific guidance numbers beyond the fair-value narrative.
Raised profitability guidance alongside slower cloud conversion timing suggests near-term revenue timing risk but improving margin durability.
Guidance raise with improving non-GAAP profitability and cash-generation expectations likely supports near-term upside bias, but GAAP operating loss widened.
Raised EBITDA and cloud-growth outlook, but slower cloud-conversion pace and longer sales cycles temper near-term confidence.
alphai scores every news story that mentions VERX with an AI model for sentiment and relevance, and aggregates insider trades from Vertex, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Vertex, Inc. (VERX) shares rose about 6.5% after it reported Q2 revenue of $203.97 million and returned to quarterly profitability. The company updated 2026 guidance and named three senior leaders, including Bala Chandran as Chief Product and Technology Officer, to support SaaS and AI initiatives and international expansion.
6 min readSimply Wall St reports Vertex (VERX) posted Q2 2026 revenue of $203.97 million and positive net income, updated revenue guidance, and appointed three senior leaders. The article cites a fair value of $18.54 versus a $13.26 latest close, implying 29% undervaluation, and links upside to European e-invoicing mandates in 2026-2027.
5 min readVertex, Inc. (VERX) reported Q2 2026 revenue of $204 million, up 10.5% year over year and at the high end of guidance. Adjusted EBITDA rose 33% to $51 million, with margin expanding to 25.0%. Subscription revenue grew to $174.8 million and ARR reached $703.4 million. Full-year revenue guidance was narrowed to $825-$830 million and adjusted EBITDA guidance raised to $206-$210 million.
6 min readVertex (NASDAQ: VERX) raised its 2026 adjusted EBITDA outlook to $206M-$210M after Q2 revenue rose 10.5% to $204M and cloud revenue grew 17.9% to $101.7M. Full-year revenue guidance was narrowed to $825M-$830M, with 18% cloud growth expected. Q2 adjusted EBITDA rose 32.8% to $51M.
4 min readVertex (NASDAQ:VERX) said slower cloud conversion is a timing issue, with customers using mixed cloud and on-prem deployments. Management highlighted strong e-invoicing momentum ahead of France and Germany mandates, expecting e-invoicing to affect ARR in Q3 and more in Q4. Q3 guidance: revenue $208M-$211M, adj. EBITDA $55M-$57M; full-year revenue $825M-$830M and adj. EBITDA $206M-$210M.
6 min readSimply Wall St reports Vertex (VERX) shares fell about 8% to $12.39 after Q2 results. Revenue rose to about $204m and the company swung to profit, with basic EPS of $0.06 and adjusted EBITDA of $51m (25% margin). Cloud and e-invoicing growth guidance and execution concerns left investors divided.
4 min readVertex Pharmaceuticals shares fell 12.8% after its post-close Q2 2026 results. The company reported EPS of $0.20 vs $0.19 consensus and revenue of $203.97M vs $202.29M forecast, but Q3 2026 revenue guidance of $208M-$211M (midpoint below ~$211.69M consensus) and free cash flow of $2.7M disappointed. Morgan Stanley downgraded to Equal Weight and cut its price target to $15 from $19.
4 min readVertex Inc. (NASDAQ:VERX) shares dropped 13.2% after its Q2 results missed cloud growth expectations and analysts cut price targets. DA Davidson lowered its target to $12 from $15, citing slower cloud conversions and reduced FY26 cloud growth guidance to 18% from 25%. Other analysts also adjusted targets following guidance and deal-cycle comments.
3 min readVertex Inc (NASDAQ:VERX) reported Q2 EPS of $0.20, above the $0.19 consensus, and sales of $203.97 million, above $202.30 million. For Q3, it guided revenue of $208.0 million to $211.0 million versus $211.70 million expected. Shares fell about 2% to $13.13 premarket as analysts lowered forecasts and adjusted price targets.
2 min readVertex Inc. (NASDAQ: VERX) said it added Chatelle Lynch as Chief People Officer, Carlos Mercuriali as SVP and Europe Regional Manager, and Bala Chandran as Chief Product and Technology Officer. The company cited experience from The RealReal, McAfee, Avalara, Amazon, and Oracle, aiming to support global growth, SaaS transformation, and AI-first product development.
2 min read
